{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:54:40Z","timestamp":1792450480312,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clinbiochem.2025.111038","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:30:34Z","timestamp":1762360234000},"page":"111038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Decoding the interference: How therapeutic monoclonal antibodies challenge serum protein electrophoresis and immunofixation"],"prefix":"10.1016","volume":"140","author":[{"given":"Julie","family":"Milandri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Jaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariette","family":"Laffineur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Dechomet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie N.","family":"Kolopp-Sarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.clinbiochem.2025.111038_b0005","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/ajh.27422","article-title":"Multiple myeloma: 2024 update on diagnosis, risk stratification, and management","volume":"99","author":"Rajkumar","year":"2024","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0010","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/jalm.2016.020784","article-title":"Identification of friend or foe: the laboratory challenge of differentiating M-proteins from monoclonal antibody therapies","volume":"1","author":"Mills","year":"2016","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/clinchem\/48.1.204","article-title":"Effect of piperacillin-tazobactam on clinical capillary zone electrophoresis of serum proteins","volume":"48","author":"Bossuyt","year":"2002","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0020","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1515\/CCLM.2008.281","article-title":"Effect of ampicillin-sulbactam on clinical capillary zone electrophoresis of serum proteins","volume":"46","author":"Siede","year":"2008","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0025","first-page":"47","article-title":"Serum protein electrophoresis in clinical biology: interferences and confounding factors","volume":"2018","author":"Cellier","year":"2018","journal-title":"Rev. Fr. Lab."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0030","doi-asserted-by":"crossref","unstructured":"Huls F, Schroeder L, Keren DF. Expression of Daratumumab and Elotuzumab Migration by Capillary Electrophoresis Relative to Transferrin Improves Precision of Their Identification. J. Appl. Lab. Med. 5 (2020) 419-22. https:\/\/doi: 10.1093\/jalm\/jfz008.","DOI":"10.1093\/jalm\/jfz008"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0035","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1515\/cclm-2013-0898","article-title":"Interference of therapeutic monoclonal immunoglobulins in the investigation of M-proteins","volume":"52","author":"Ruinemans-Koerts","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0040","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1373\/clinchem.2016.270090","article-title":"A new monoclonal band in a patient with refractory multiple myeloma","volume":"63","author":"Willard","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/0004563217710489","article-title":"Electrophoretic patterns post daratumumab","volume":"55","author":"Sheldon","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0050","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.3390\/ijms24043136","article-title":"Monoclonal antibodies: the greatest resource to treat multiple myeloma","volume":"24","author":"De Luca","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0055","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJMoa2203478","article-title":"Teclistamab in relapsed or refractory multiple myeloma","volume":"387","author":"Moreau","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0060","unstructured":"European Medicines Agency, Soliris, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/soliris , 2025 (accessed Aug 2025)."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0065","unstructured":"European Medicines Agency, Ultomiris, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ultomiris , 2025 (accessed Aug 2025)."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0070","doi-asserted-by":"crossref","unstructured":"S. Liang, W. Feng, H. Ma, L. Zhang, C. Jia, False positive results: a challenge for laboratory physicians and hematologists in treating multiple myeloma with daratumumab, Hematology 27 (2022) 332\u2013336. doi: 10.1080\/16078454.2022.2045723.","DOI":"10.1080\/16078454.2022.2045723"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1373\/jalm.2019.029009","article-title":"Incidence and management of therapeutic monoclonal antibody interference in monoclonal gammopathy monitoring","volume":"5","author":"Liu","year":"2020","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/00045632211062080","article-title":"Case report: interference from isatuximab on serum protein electrophoresis prevented demonstration of complete remission in a myeloma patient","volume":"59","author":"Wheeler","year":"2022","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clinbiochem.2016.09.015","article-title":"Treatment of multiple myeloma with monoclonal antibodies and the dilemma of false positive M-spikes in peripheral blood","volume":"51","author":"Murata","year":"2018","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood-2020-136613","article-title":"Development of a Hydrashift 2\/4 isatuximab assay to mitigate interference with monoclonal protein detection on immunofixation electrophoresis in vitro diagnostic tests in multiple myeloma","volume":"136","author":"Finn","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2023.113552","article-title":"Identifying therapeutic monoclonal antibodies using target protein collision electrophoresis reflex assay to separate the wheat from the chaff","volume":"522","author":"Teuwen","year":"2023","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pathol.2022.05.014","article-title":"Monoclonal antibody interference in electrophoresis","volume":"55","author":"Malik","year":"2023","journal-title":"Pathology"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0105","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1515\/cclm-2015-1023","article-title":"Monoclonal antibody therapeutics as potential interferences on protein electrophoresis and immunofixation","volume":"54","author":"Willrich","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0110","unstructured":"European Medicines Agency, Tecvayli, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/tecvayli , 2025 (accessed Aug 2025)."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0115","doi-asserted-by":"crossref","unstructured":"European Medicines Agency, Elrexfio, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/elrexfio , 2025 (accessed Aug 2025). [24] A. R\u00f6th, C. Hock, A. Konik, S. Christoph, U. D\u00fchrsen, Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena, Int. J. Hematol. 93 (2011) 704\u2013714. doi: 10.1007\/s12185-011-0867-y.","DOI":"10.1007\/s12185-011-0867-y"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0120","doi-asserted-by":"crossref","unstructured":"A. R\u00f6th, C. Hock, A. Konik, S. Christoph, U. D\u00fchrsen, Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena, Int. J. Hematol. 93 (2011) 704\u2013714. doi: 10.1007\/s12185-011-0867-y.","DOI":"10.1007\/s12185-011-0867-y"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0125","unstructured":"European Medicines Agency, Darzalex, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/darzalex , 2025 (accessed Aug 2025)."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0130","unstructured":"European Medicines Agency, Sarclisa, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/sarclisa , 2025 (accessed Aug 2025)."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0135","doi-asserted-by":"crossref","unstructured":"G. Salles, M. Barrett, R. Fo\u00e0, J. Maurer, S. O\u2019Brien, N. Valente, et al., Rituximab in B-cell hematologic malignancies: a review of 20 years of clinical experience, Adv. Ther. 34 (2017) 2232\u20132273. doi: 10.1007\/s12325-017-0612-x.","DOI":"10.1007\/s12325-017-0612-x"},{"key":"10.1016\/j.clinbiochem.2025.111038_b0140","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1515\/cclm-2024-0416","article-title":"Evaluating the Hydrashift 2\/4 Daratumumab assay: a powerful approach to assess treatment response in multiple myeloma","volume":"62","author":"Lee","year":"2024","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0145","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1515\/cclm-2015-1031","article-title":"Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interference","volume":"54","author":"McCudden","year":"2016","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2025.111038_b0150","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1515\/cclm-2015-0888","article-title":"Interference of daratumumab in monitoring multiple myeloma patients using serum immunofixation electrophoresis can be abrogated using the daratumumab IFE reflex assay (DIRA)","volume":"54","author":"van de Donk","year":"2016","journal-title":"Clin. Chem. Lab. Med."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912025001675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:43:04Z","timestamp":1783158184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912025001675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":30,"alternative-id":["S0009912025001675"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111038","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding the interference: How therapeutic monoclonal antibodies challenge serum protein electrophoresis and immunofixation","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2025.111038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of The Canadian Society of Clinical Chemists.","name":"copyright","label":"Copyright"}],"article-number":"111038"}}